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S  U  M  M  A R  Y 
 
Parasites threaten human and animal health globally. It is estimated that more than 60% of people on 
planet Earth carry at least one parasite, many of them several different species. Unfortunately, parasite 
studies suffer from duplications and inconsistencies between  different investigator groups. Hence, 
groups need to collaborate in an integrated manner in areas including parasite control, improved therapy 
strategies, diagnostic and surveillance tools, and public awareness. Parasite studies will be better served 
if there is coordinated management of field data and samples across multidisciplinary approach plans, 
among academic and non-academic organizations worldwide. In this paper we  report the first ‘Living 
organism-World Molecular Network’, with the cooperation of 167 parasitologists from 88  countries on 
all continents. This  integrative approach, the ‘Sarcoptes-World Molecular Network’, seeks to harmonize 
Sarcoptes epidemiology, diagnosis, treatment, and molecular studies from all  over the world, with the 
aim of decreasing mite infestations in  humans and animals. 
. 
 
 
 
 
 
1.  The  parasite and the disease 
 
Sarcoptes   scabiei    causes  sarcoptic  mange   in    companion, 
livestock, and wild animals, as  well as  scabies in  humans.  This 
parasite has a very broad host range, which includes more than 100 
mammalian species belonging to  27  families from 10  orders.1  In 
addition to   its   potential to   cause huge  economic loss   due to 
reduced production and increased mortality in animals,1–3  scabies 
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is   an   emerging/re-emerging infectious disease that  threatens 
human and animal health globally.4–6  There are  no  accurate 
estimates of  the prevalence of  sarcoptic mange in  many of  the 
different animal populations affected worldwide. However, there 
are  several examples of how serious an S. scabiei  epidemic can  be, 
causing devastating morbidity.1 
It is estimated that 300  million people are  infested with scabies 
worldwide.7,8  This  conservative estimate is  most likely too  low 
considering that the infection is  frequently not reported in 
humans.9 The  prevalence of scabies in African children can  be  as 
high as  40–80%,10,11 and in  remote indigenous communities in 
northern Australia, up  to  50% of children and 25% of adults were 
 
  
 
 
 
 
found  to   be   infested.12   In   developing  countries,  scabies  is   a 
significant public health problem because it is highly prevalent and 
complications are frequent.13 These may include, in the presence of 
bacterial superinfection, acute post-streptococcal glomerulone- 
phritis (PSGN). Children appear to be more commonly affected by 
streptococcal superinfection,14  and complications such as  PSGN 
may be fatal.15 A study performed in The Gambia showed that skin 
lesions associated with scabies were the leading portal of entry for 
organisms causing septicemia in infants aged 3 months or  less.16 
The presence and severity of scabies are often associated with poor 
living conditions and illiteracy.17  Introduction of a single case of 
scabies into crowded living conditions can  result in  an  epidem- 
ic.18,19 The disease is also  a curse in high-income countries where 
the prevalence may be  increasing due to  diagnostic failures, 
suspected resistance against some acaricides, and perhaps changes 
in social habits.20 
Chemotherapy of scabies is important in clinical work. Cheap, 
safe,  and efficacious drugs are  not commonly available in some of 
the poorer countries. Emerging drug resistance to  S. scabiei  has 
recently been reported from regions where previously effective 
acaricides have been used extensively in  socially disadvantaged 
communities and in some developing countries.21–23 Researchers 
are  addressing this in  various ways, e.g.,  by  testing (identifying) 
novel chemotherapeutics,24–26   by  immunological intervention, 
and/or by  molecular studies of the mite, including, for  example, 
investigating whether  glutathione transferases (GSTs)  play any 
role  in conferring acaricide resistance to  S. scabiei  and other 
mechanisms.27–31 
The diagnosis of Sarcoptes is pivotal for assessing eradication 
programs32–34  and for epidemiological studies.35 For the experi- 
enced dermatologist,  the clinical diagnosis of  scabies may not 
appear difficult, but in  fact  scabies continues to be  a diagnostic 
challenge36  because of its diverging clinical manifestations and 
many differential diagnoses.24   The  definitive diagnosis of 
Sarcoptes infestation  can   be  difficult as  in  many cases only a 
few mites are present on an infested host, and skin manifestations 
can  be  subtle or atypical.37  There is a lack  of accurate diagnostic 
tests for  humans.24,38  In  addition, for  many domestic and wild 
animals, including threatened species such as Chamois and 
Gorillas,39,40 better specific Sarcoptes diagnostic methods need to 
be  developed. 
For  many years, parasitologists have been immersed in  an 
ongoing debate as to ‘‘whether or not S. scabiei  infecting different 
hosts belong to  different species or  sub-species, or  whether they 
are,  in fact,  monospecific’’.4  Today, the species Sarcoptes scabiei  is 
divided into varieties based on the host species, e.g., S. scabiei  var. 
hominis and S. scabiei   var.  canis.   Humans can   be  infested with 
animal varieties, but in this case the disease is usually limited to 
certain topographic sites and is self-limited. It has been shown that 
an  epidemiological relationship does not exist between sarcoptic 
mange foci,41 while morphological studies have failed to  identify 
any    significant  differences  between   populations  of   mites.42 
Experimental cross-contamination of  hosts with some different 
S. scabiei  varieties is  commonly unsuccessful,43  however, cross- 
transmission/infection is common in some varieties, e.g., S. scabiei 
var.  vulpes/canis readily infect dogs and other  canids as  well as 
felids, including domestic European cats.2  In addition, this variety 
of  S. scabiei  also  readily infects/infests humans causing pseudo- 
scabies.2   Research into  finding  an   answer  to   the  question  of 
whether or not S. scabiei  is a single species and understanding the 
‘host-specificity’ of the mite has  advanced in the last decade with 
the advent of  polymerase chain reaction (PCR)  technology and 
molecular marker systems in  the genetic era.  Molecular studies 
based on  short fragments of  mitochondrial or  ribosomal  DNA 
spacer regions failed to  identify S. scabiei  populations to  the host 
species level and  geographical localities.42,44–47    Studies on   a 
central fragment of the 16S  gene and the complete cytochrome c 
oxidase subunit I gene gene (COI) in combination with microsat- 
ellite markers provided some support for a genetic differentiation 
of S. scabiei.  These genetic markers demonstrated  significant 
relationships between S. scabiei  mitochondrial DNA (mtDNA) 
haplotypes and microsatellite allele frequencies, and host species 
and geographical locations, even at skin-scale level.48–50 Immuno- 
logical studies have shown that each variety of  S. scabiei  tested 
produces a range of proteins, both variety-specific and immuno- 
logically identical and shared by  the different mite sub-types.51 
Clinical manifestations  of scabies range from singular nodules 
to severe crusted scabies. The underlying causes for these different 
manifestations may be found in the immunological host response, 
but are  not fully  understood. 
In summary, there is ongoing debate about the host specificity 
and range of different Sarcoptes populations on a worldwide scale. 
The   taxonomical  status  of   this  important  parasite  remains 
unclear. Sensitive diagnostic methods are  still  not available for 
many host species, including humans, and new therapeutic 
options need to be  evaluated.  Therefore, well-designed studies 
aimed  at  better  understanding  the  world epidemiology and 
transmission dynamics, and the design and development of 
sensitive and specific diagnostic methods are  of paramount 
importance. 
 
2.  Sarcoptes-World Molecular Network initiative 
 
During the last few  years we  have been working on  Sarcoptes 
mite epidemiology, diagnosis, treatment, control, clinical aspects, 
and genetics, and we are in touch with colleagues who are working 
on  Sarcoptes mite epidemiology and control worldwide. This  has 
enabled us  to  create  the  ‘Sarcoptes-World Molecular Network’ 
(WMN), which  currently  includes  167   parasitologists from 88 
countries from all  continents. The  Sarcoptes-WMN aims to  be  a 
facilitator of  collaborative, mainly molecular research on  Sar- 
coptes.  The   network  will   bring together  a  wide  spectrum  of 
research communities, aiming to  share information, expertise, 
samples, and infrastructure. The  Sarcoptes-WMN includes differ- 
ent institutions such as  universities, hospitals, centers of animal 
health, medical colleges, public health institutes, private clinics, 
medical centers, biological institutes, veterinary research labora- 
tories, animal health services, clinical research centers, public 
health institutes, and wildlife conservation institutes worldwide. 
 
3.  Overall strategy of the Sarcoptes-World Molecular Network 
 
The Sarcoptes-WMN plans to ‘pump-prime’ a new genetic era of 
research into this important parasite, with the aim  of achieving the 
following: 
 
1. Technology and  knowledge transfer  among specialists and 
human and veterinary practitioners all  over the world on  the 
diagnosis, epidemiology, and management of Sarcoptes scabiei 
infestations. This  will  prevent Sarcoptes research duplication 
and foster protocol uniformity, which would fast-track world 
research on  Sarcoptes. 
2. Increase knowledge on  the world epidemiology of this ubiqui- 
tous parasite. 
3. The design and development of universal and specific Sarcoptes 
PCR-based and antibody-based diagnostic methods. 
4. Create a global open access ‘Sarcoptes-Specimens World Bank’. 
5. Create a global open access ‘Sarcoptes-gDNA World Bank’. 
6. Create a  global open access database on  the world molecular 
systematics of  the species Sarcoptes, inferred from molecular 
marker data from thousands of individual Sarcoptes specimens 
worldwide. 
  
 
 
 
 
7. Examine the long-term evolutionary history undergone by this 
ectoparasite, and establish a possible scenario for  Sarcoptes 
migration throughout the world. 
8. Formulate public and animal health control policies with the 
aim   of  decreasing  S.  scabiei   infections  in   humans  and  in 
animals. 
 
4.  Conclusions 
 
The concept of ‘network’ plays a central role in all branches of 
our  life. In the area of parasitology research, it is crucial to realize 
the importance of  standardizing research protocols worldwide. 
Availability of biological samples is a recognized limiting factor 
for biological and genetic studies; hence the creation of a global 
open access ‘Living organism-Specimens/gDNA World Bank’ is of 
pivotal interest. Sufficiently robust and well-standardized diag- 
nostic methods are  needed in the form of ready-to-use kits  in the 
routine laboratory for  many host-derived parasite species. The 
accurate estimation of parasite host specificity and range will only 
be  achieved by global epidemiology and molecular studies. 
Sarcoptes-WMN is just starting its  operations in terms of 
technology and knowledge transfer among its members, Sarcoptes 
specimen collection, and the design of  the epidemiological/ 
molecular studies. We  are  aware that such a world genetic 
epidemiology study in  different host species, countries, and 
geographical areas requires wider awareness and collaborations 
from all  sectors concerned in  animal/human welfare, and 
especially from those interested in the disease. 
To our  knowledge this is  the first world molecular network, 
which we  hope will  serve as  a framework around which further 
‘Living  being-World Molecular Networks’ (Anima-WMN) will  be 
constructed. 
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